[1]
“Synthesis, anticancer evaluation, and molecular docking studies of Vanillin-2,4-thiazolidinedione-Triazole hybrid analogues”, IJC, vol. 64, no. 8, pp. 836–845, Aug. 2025, doi: 10.56042/ijc.v64i8.18610.